SUBSCRIBE
SUBSCRIBE

Radiopharmaceuticals

Tumor microenvironment concept with cancer cells, T-Cells, nanoparticles, cancer associated fibroblast layer of tumor microenvironment normal cells, molecules, and blood vessels 3d rendering
Cancer
ADCs, Bispecifics and Radiopharma Take Center Stage at ESMO24
The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer treatment—antibody-drug conjugates, bispecifics and radiopharmaceuticals—while anti-TIGIT therapies made a bit of a comeback.
September 20, 2024
 · 
3 min read
 · 
Greg Slabodkin
PRESS RELEASES
News
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players
September 19, 2024
 · 
10 min read
Press Releases
ITM to Present at Upcoming Radiopharmaceutical Investor Conferences in New York City
September 19, 2024
 · 
2 min read
Press Releases
Laurentis signs MOU with Colibri to pursue isotopes irradiation services
September 18, 2024
 · 
3 min read
Press Releases
GlyTherix to Partner with SHINE Technologies for Advancing Targeted Radiotherapy in Aggressive Cancers
September 18, 2024
 · 
4 min read
Press Releases
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
September 18, 2024
 · 
7 min read
Press Releases
Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024
September 16, 2024
 · 
10 min read
Press Releases
Alume Biosciences Appoints Rick Gonzalez as Chief Commercial Officer
September 13, 2024
 · 
2 min read
Press Releases
Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
September 13, 2024
 · 
5 min read
Press Releases
MTTI Reports on Fast-Acting Sprayable Molecule to Visualize Tumors for Real-Time Fluorescence-Guided Cytoreductive Surgery
September 12, 2024
 · 
2 min read
Press Releases
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
September 12, 2024
 · 
6 min read
Press Releases
Press Release: Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers
September 12, 2024
 · 
10 min read
Press Releases
MTTI at the 2nd Annual Targeted Radionuclide Pharmaceuticals Supply Chain & Manufacturing Summit
September 11, 2024
 · 
2 min read
Press Releases
‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
September 11, 2024
 · 
9 min read
Press Releases
Curium Announces PYLCLARI® – An Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer – Is Now Available in Spain
September 10, 2024
 · 
2 min read
Press Releases
Nurix Therapeutics To Participate in Upcoming ADC & Radiopharmaceuticals Pharma & Biotech Partnering Summit
September 6, 2024
 · 
1 min read
Press Releases
Novartis begins construction of two new radioligand therapy facilities in the US, expanding its world-class RLT manufacturing and supply network
September 5, 2024
 · 
13 min read
Press Releases
Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 4, 2024
 · 
1 min read
Drug Development
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
September 3, 2024
 · 
9 min read
Press Releases
IBA Reports Half Year 2024 Results
August 29, 2024
 · 
6 min read
Press Releases
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
August 28, 2024
 · 
5 min read
Load More